About Genewize
Genomic science is the scientific understanding and mapping of the human DNA. The human DNA is made up of 26 pairs of chromosomes. The largest scientific collaboration ever in history is the Human Genome Project. It was bigger than the Manhattan projects, which created the nuclear bomb; bigger than the Apollo project; which landed men on the moon. The completion of the Genomics Project gives us a whole new level of tools and understanding.
Genomic science has identified every single molecule on every single chain of all 26 pairs of Chromosomes. The scientific ability to unravel, decode and have an exact map, for a person, as if they were able to be typed out in a binary book of one million pages of 1’s and 0’s is what has been achieved. We have cracked the code of the DNA riddle. Science has mapped 100 human beings as well as animals and the difference between anybody in the world and any one else now living any place in the world only differs by 1/10th of 1% in their genetic make-up.
Genewize is the one of a handful of companies in the world currently possessing this level of science, and using it exclusively in a non-drug, holistic nutritional program of support. The ability to decode the human genome is being used for the first time to decode the benefits of nutritional plants, to benefit humans. The human DNA is the basics of human development. Recently the human DNA code has been cracked. The mystery has been decoded and can be seen for the first time in history. A joint conference of President, William Jefferson Clinton, and Tony Blair, the Prime Minister of England, announced that Genomic science was the biggest breakthrough in the biological sciences, since the microscope.
DNA is a redundant, overlapping, self replicating, error correcting quaternary, multi-level digital code. Nothing has ever been observed to be this complex. DNA is a work of such divine and profound complexity, that it is unique.
Genewize is THE unique company bringing better health to the marketplace with this research.
Trackback this post | Subscribe to the comments via RSS Feed